BLD-2660
(IPF)
Phase 1
Revolutionizing the Treatment of Fibrotic Disease.
Revolutionizing the Treatment of Fibrotic Disease.
Revolutionizing the Treatment of Fibrotic Disease.
Pipeline
We are positioned to build a pipeline across a range of fibrotic diseases.
BLD-2660
(NASH)
Phase 1
BLD-0409
(formerly PAT-409)
Phase 1
BLD-2184
(Neurodegeneration)
Preclinical
Join our team
We are looking for people with the passion and commitment of the values we live by.
Passion and commitment to our mission
Accountability to the team
Integrity in everything we do
Be fearless
Recent News
Sept 25, 2019
Bringing life changing and revolutionary treatments to patients with fibrotic diseases.